home / stock / octhf / octhf short
Short Information | Oxford Cannabinoid (OTCMKTS:OCTHF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 116,624 |
Total Actual Volume | 164,749 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 11 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 5,831 |
Average Short Percentage | 52.88% |
Is there a OCTHF Short Squeeze or Breakout about to happen?
See the OCTHF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-08-2024 | $0.0419 | $0.0028 | $0.0419 | $0.0028 | 45,110 | 12,610 | 27.95% |
05-07-2024 | $0.0443 | $0.0443 | $0.0443 | $0.0443 | 500 | 500 | 100% |
04-08-2024 | $0.0051 | $0.0051 | $0.0051 | $0.0051 | 58,000 | 48,000 | 82.76% |
03-27-2024 | $0.0058 | $0.0058 | $0.0058 | $0.0058 | 32,584 | 32,584 | 100% |
02-22-2024 | $0.0058 | $0.0058 | $0.0058 | $0.0058 | 9,445 | 9,445 | 100% |
07-13-2022 | $0.01 | $0.01 | $0.01 | $0.01 | 5,000 | 5,000 | 100% |
02-22-2022 | $0.034 | $0.034 | $0.034 | $0.034 | 200 | 200 | 100% |
01-31-2022 | $0.039 | $0.036 | $0.039 | $0.036 | 2,500 | 1,000 | 40% |
01-03-2022 | $0.25 | $0.25 | $0.25 | $0.25 | 160 | 160 | 100% |
12-15-2021 | $0.03 | $0.0489 | $0.0489 | $0.03 | 7,250 | 4,125 | 56.9% |
12-08-2021 | $0.048 | $0.048 | $0.048 | $0.048 | 1,000 | 1,000 | 100% |
12-01-2021 | $0.1 | $0.1 | $0.1 | $0.1 | 2,000 | 1,000 | 50% |
11-12-2021 | $0.035 | $0.035 | $0.035 | $0.035 | 1,000 | 1,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF) CEO Clarissa Sowemimo Coker and CMO Dr Tim Corn speak to Thomas Warner from Proactive after the pharmaceutical group announced the appoint of Corn to its board of directors. The move follows his appointmen...
--News Direct-- Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) chief executive Clarissa Sowemimo-Coker speaks to Thomas Warner from Proactive London after the pharmaceutical group announced phase 1 clinical trial results for its lead drug candidate OCT461201. Sow...
--News Direct-- Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) chief executive Clarissa Sowemimo-Coker speaks to Thomas Warner from Proactive London after the pharmaceutical group announced it has successfully administered the final dose of its lead drug candidate, O...